Last update 30 Mar 2025

Recombinant novel coronavirus Beta/Omicron (BA.1/BQ.1.1/XBB.1) S trimeric protein vaccine (Sinocelltech)

Overview

Basic Info

Drug Type
Recombinant protein, Prophylactic vaccine
Synonyms
重组新冠病毒Beta/Omicron(BA.1/BQ.1.1/XBB.1)变异株S三聚体蛋白疫苗(神州细胞), 重组新冠病毒Beta/Omicron变异株S三聚体蛋白疫苗 (神州细胞), SCTV01E-2
+ [1]
Target
SARS-CoV-2 S protein
Action
inhibitors
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
Sinocelltech Group Ltd.Sinocelltech Group Ltd.
Active Organization
Sinocelltech Group Ltd.Sinocelltech Group Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Dec 2023),
COVID-19
RegulationEmergency Use Authorization (China)
Login to view timeline

Related

100 Clinical Results associated with Recombinant novel coronavirus Beta/Omicron (BA.1/BQ.1.1/XBB.1) S trimeric protein vaccine (Sinocelltech)
Login to view more data
100 Translational Medicine associated with Recombinant novel coronavirus Beta/Omicron (BA.1/BQ.1.1/XBB.1) S trimeric protein vaccine (Sinocelltech)
Login to view more data
100 Patents (Medical) associated with Recombinant novel coronavirus Beta/Omicron (BA.1/BQ.1.1/XBB.1) S trimeric protein vaccine (Sinocelltech)
Login to view more data
100 Deals associated with Recombinant novel coronavirus Beta/Omicron (BA.1/BQ.1.1/XBB.1) S trimeric protein vaccine (Sinocelltech)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
COVID-19
China
Sinocelltech Group Ltd.Sinocelltech Group Ltd.
01 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free